Pharvaris (PHVS) Enterprise Value (2021 - 2026)

Pharvaris (PHVS) has 8 years of Enterprise Value data on file, last reported at -$289.1 million in Q1 2026.

• Quarterly Enterprise Value fell 16.22% year-over-year to -$289.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$289.1 million (down 16.22% YoY) and the FY2025 annual result came in at -$329.5 million, down 8.46% from the prior year.
• Enterprise Value rose to -$289.1 million in Q1 2026, from -$339.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$145.1 million in Q1 2023 to a low of -$420.9 million in Q4 2023.
• A 5-year average of -$272.1 million and a median of -$248.8 million in 2025 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2024 — Enterprise Value plunged 175.79% — and 2025, when it surged 38.94%.
• Tracing PHVS's Enterprise Value over 5 years: stood at -$165.1 million in 2022, then tumbled by 154.94% to -$420.9 million in 2023, then grew by 28.73% to -$300.0 million in 2024, then retreated by 13.18% to -$339.5 million in 2025, then increased by 14.84% to -$289.1 million in 2026.
• The last three Enterprise Value figures came in at -$289.1 million (Q1 2026), -$339.5 million (Q4 2025), and -$385.0 million (Q3 2025), per Business Quant data.